| T. Rowe Price Health Sciences Port |
|
 |
|
| Release date as of 2024-03-31. Data on page is subject to change. |
|
|
| Style Box Details for Stock Holdings |
|
| Size |
|
| Average Mkt Cap $Mil |
71,617 |
|
|
|
| Market Capitalization |
% of Portfolio |
| Giant |
27.38 |
| Large |
37.19 |
| Medium |
19.66 |
| Small |
11.04 |
| Micro |
4.73 |
| |
|
|
| Investment Valuation |
Stock
Portfolio
|
| Forward P/E |
24.1 |
| Price/Book |
5.2 |
| Price/Sales |
2.0 |
| Price/Cash Flow |
21.3 |
| Dividend Yield |
0.7 |
| Long-Term Earnings |
11.8 |
| Historical Earnings |
1.7 |
| Sales Growth |
13.0 |
| Cash-Flow Growth |
2.7 |
| Book-Value Growth |
6.3 |
|
|
|
 |
|
| As of 2024-03-31 |
|
|
|
| % of Net Assets |
 |
U.S. Stocks |
83.5 |
 |
Non-U.S. Stocks |
6.7 |
 |
Bonds |
0.0 |
 |
Cash |
0.3 |
 |
Other |
9.6 |
|
|
 |
| Data through 2024-03-31 |
|
|
|
| Morningstar Equity Sectors |
|
|
|
% of Stocks |
 |
Cyclical |
0.00 |
 |
Basic Materials |
0.00 |
 |
Consumer Cyclical |
0.00 |
 |
Financial Services |
0.00 |
 |
Real Estate |
0.00 |
|
|
|
 |
Sensitive |
0.00 |
 |
Communication Services |
0.00 |
 |
Energy |
0.00 |
 |
Industrials |
0.00 |
 |
Technology |
0.00 |
|
|
|
 |
Defensive |
100.00 |
 |
Consumer Defensive |
0.00 |
 |
Healthcare |
100.00 |
 |
Utilities |
0.00 |
|
| Data through 2024-03-31 |
|
|
|
|
| Total Number of Stock Holdings |
137 |
| Total Number of Bond Holdings |
0 |
| % of Net Assets in Top 10 Holdings |
50.36 |
|
|
| Turnover % |
(as of 2023-12-31) |
49.50 |
| 30 Day SEC Yield % |
0.00 |
|
|
Sector |
P/E |
% of Net
Assets
|
 |
|
|
|
|
 |
Eli Lilly and Co |
|
134.13 |
9.90 |
 |
Aggregate Miscellaneous Equity |
--- |
--- |
9.37 |
|
UnitedHealth Group Inc |
|
20.73 |
6.08 |
|
Intuitive Surgical Inc |
|
79.34 |
4.14 |
|
Merck & Co Inc |
|
942.50 |
4.06 |
 |
|
Thermo Fisher Scientific Inc |
|
37.62 |
4.03 |
|
Stryker Corp |
|
43.38 |
3.63 |
|
Elevance Health Inc |
|
20.56 |
3.55 |
|
Danaher Corp |
|
44.20 |
2.92 |
|
Regeneron Pharmaceuticals Inc |
|
27.68 |
2.68 |
|
|
Vertex Pharmaceuticals Inc |
|
30.09 |
2.10 |
|
argenx SE ADR |
|
--- |
2.00 |
|
AstraZeneca PLC ADR |
|
--- |
1.99 |
|
The Cigna Group |
|
20.88 |
1.86 |
|
Amgen Inc |
|
22.76 |
1.60 |
|
|
Novo Nordisk A/S ADR |
|
--- |
1.50 |
|
Molina Healthcare Inc |
|
21.89 |
1.45 |
|
Edwards Lifesciences Corp |
|
41.55 |
1.32 |
|
Alnylam Pharmaceuticals Inc |
|
--- |
1.30 |
|
Blueprint Medicines Corp |
|
--- |
1.30 |
|
|
Agilent Technologies Inc |
|
34.81 |
1.08 |
|
Penumbra Inc |
|
96.20 |
1.07 |
|
Becton Dickinson & Co |
|
56.75 |
1.07 |
|
HCA Healthcare Inc |
|
17.58 |
1.06 |
|
Boston Scientific Corp |
|
64.01 |
1.04 |
|
|
 |
|
|
© Copyright 2024 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or any losses arising from any use of information. Past performance is no guarantee of future performance. |
|
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.
|
|
